Mean values and 95% confidence intervals for resting flow, arterial occlusion pressure (AOP), biological zero, reactive hyperemia (RHmax), and time to peak across the three conditi... by Robert Trybulski (10998702)

Subjects:

Fig 4 - by Leena Inkilä (20614460)

Average ratio of the concentrations obtained with qPCR, before and after DNase treatment, and with DAO before DNase treatment of the ISP phage stocks. by Saar Van Overfelt (20378458)

Subjects:

Average concentration of the ISP phage stocks obtained with qPCR, before and after DNase treatment, and with the DAO method before the DNase treatment. by Saar Van Overfelt (20378458)

Subjects:

Visualization of DNA in an untreated ISP phage stock by immunogold labelling. by Saar Van Overfelt (20378458)

Subjects:

Experimental set up to determine the impact of DNase treatment of ISP phage stocks with different storage periods (ISP-1, ISP-2 and ISP-3) on the quantification with qPCR and the a... by Saar Van Overfelt (20378458)

Subjects:

Estimates of the average yearly citations per publication (including all publications) by scholar group, misconduct type, and time. by Giulia Maimone (20833354)

Isotopic niche area (‰²) estimates for native fish species from non-colonized (River Mamoré) and colonized (Madre de Dios River) lakes. by Danny Rejas (583637)

Analysis of variance results (mean sum of squares and significance) for the effect of soil types, crop species, and diuron doses on plant and their interactions on crop growth resp... by Win Win Pyone (20396432)

Global and national estimates of disability-adjusted life years (DALYs) due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Prais–Winsten AR(1) Regression with Iterated Estimates. by Muhummad Khairul Islam (21955544)

Subjects:

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Dose determination and cell viability estimation of (A) NF-Orientin and (B) Native Orientin using MCF-7 cell lines. by Yashwanth Elumalai (21743452)

Genera associated with FC, symptom score or week to treatment. by Katrine Carlsen (5477300)

Subjects:

Estimated and observed disease prevalence in school-aged children by area, test and sampling year. by Roland Proud (11764892)

Estimation Results of the Cox Proportional Hazards Model. by Fangyi Yang (18867853)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Effective reproduction numbers of influenza in the United States from week 40 to week 17 in 2016–2017, 2017–2018, 2018–2019, 2022–2023, and 2023–2024. by Shuanglin Jing (11886368)

Subjects: